1
|
Mejía-Barradas CM, Amador-Martínez A, Lara-Padilla E, Cárdenas-Rodríguez N, Ignacio-Mejía I, Martínez-López V, Ibañez-Cervantes G, Picado-Garcia ODJ, Domínguez B, Bandala C. Effects of Selective and Nonselective Beta Blockers on Bone Mineral Density in Mexican Patients with Breast Cancer. Cancers (Basel) 2024; 16:2891. [PMID: 39199661 PMCID: PMC11352457 DOI: 10.3390/cancers16162891] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2024] [Revised: 08/06/2024] [Accepted: 08/16/2024] [Indexed: 09/01/2024] Open
Abstract
Breast cancer (BCa) is related to chronic stress and can reduce the bone mineral density (BMD) through neurochemicals related to beta-adrenergic receptor (ADRB) 1 and 2. Selective beta blockers (sBBs) and nonselective beta blockers (nsBBs) are used to treat systemic arterial hypertension (SAH) and may have osteoprotective effects, as they inhibit ADRBs. To evaluate the effects of sBBs and nsBBs on the BMD of Mexican patients with BCa. A retrospective study was conducted. We included 191 Mexican women with BCa without SAH and with SAH treated with nsBBs, sBBs, and diuretics. BMD was evaluated using a bone density scan (DEX scan). A greater average BMD (p < 0.05) was observed in patients with prior treatment with both nsBBs and sBBs (0.54 ± 0.94 and -0.44 ± 1.22, respectively) compared to patients treated with diuretics or without SAH (-1.73 ± 0.83 and -1.22 ± 0.98, respectively). Regarding the diagnosis of osteoporosis/osteopenia, no cases were observed in patients treated with nsBBs, whereas 5.6% of the patients treated with sBBs presented osteopenia. A total of 23.1% and 10.6% patients managed with diuretics or without treatment presented with osteoporosis and 61.5% and 48% patients managed with loop diuretics and without treatment presented with osteopenia, respectively (p < 0.05). Treatment with nsBBs is a promising option for the prevention and management of osteoporosis/osteopenia in Mexican patients with BCa; however, further prospective studies are needed.
Collapse
Affiliation(s)
- César Miguel Mejía-Barradas
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico; (C.M.M.-B.); (E.L.-P.); (G.I.-C.), (B.D.)
| | - Ana Amador-Martínez
- Departamento de Radiología e Imagen, Centro Médico ABC, Mexico City 01120, Mexico;
| | - Eleazar Lara-Padilla
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico; (C.M.M.-B.); (E.L.-P.); (G.I.-C.), (B.D.)
| | | | - Iván Ignacio-Mejía
- Laboratorio de Medicina Traslacional, Escuela Militar de Graduados en Sanidad, Universidad Del Ejército y Fuerza Aérea, Mexico City 11200, Mexico;
| | - Valentín Martínez-López
- Unidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico;
| | - Gabriela Ibañez-Cervantes
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico; (C.M.M.-B.); (E.L.-P.); (G.I.-C.), (B.D.)
- División de Investigación, Hospital Juárez de México, Mexico City 07760, Mexico
| | | | - Brayan Domínguez
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico; (C.M.M.-B.); (E.L.-P.); (G.I.-C.), (B.D.)
| | - Cindy Bandala
- Escuela Superior de Medicina, Instituto Politécnico Nacional, Mexico City 11340, Mexico; (C.M.M.-B.); (E.L.-P.); (G.I.-C.), (B.D.)
| |
Collapse
|
2
|
Zhong XP, Xia WF. Regulation of bone metabolism mediated by β-adrenergic receptor and its clinical application. World J Clin Cases 2021; 9:8967-8973. [PMID: 34786380 PMCID: PMC8567525 DOI: 10.12998/wjcc.v9.i30.8967] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2021] [Revised: 07/18/2021] [Accepted: 09/01/2021] [Indexed: 02/06/2023] Open
Abstract
Recent studies have confirmed that β-adrenergic receptors (β-ARs) are expressed on the surface of osteoblasts and osteoclasts, and that the sympathetic nervous system can regulate bone metabolism by activating them. β-AR blockers (BBs) are commonly used in the treatment of cardiovascular diseases in the elderly. It is important to investigate whether BBs have a beneficial effect on bone metabolism in the treatment of cardiovascular diseases, so as to expand their clinical application. This article reviews the effects of BB on bone metabolism and the progress of clinical research.
Collapse
Affiliation(s)
- Xue-Ping Zhong
- Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China
| | - Wen-Fang Xia
- Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei Province, China
| |
Collapse
|